AngiostatinTM and EndostatinTM:endothelial cell-specific endogenous inhibitorsof angiogenesis and tumor growth B. Kim Lee Sim OriginalPaper Pages: 37 - 48
Endostatin and angiostatin: the next anti-angiogenesis generation Elise C. Kohn OriginalPaper Pages: 25 - 27
The implications of angiogenesison tumor invasiveness Gerhard Christofori OriginalPaper Pages: 21 - 23
On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components Nikos E. TsopanoglouMichael E. Maragoudakis OriginalPaper Pages: 192 - 200
Tetrahydro-derivatives of cortisone promote granulomatous tissue angiogenesis in vivo on topical application in hyaluronan Chandan AlamPaul Colville-NashDerek Willoughby OriginalPaper Pages: 185 - 191
Lipid hydroperoxide-induced tumor necrosis factor (TNF)-α, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition Toshihiko UedaTakako UedaDonald Armstrong OriginalPaper Pages: 174 - 184
New insights in the biology of fibroblast growth factor-2 Andreas BikfalviCatherine SavonaSophie Javerzat OriginalPaper Pages: 155 - 173
Distinct capillary density and progression promoted by vascular endothelial growth factor-A homodimers and heterodimers Lucia MorbidelliRalf BirkenhaegerMarina Ziche OriginalPaper Pages: 117 - 130
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice Francesco SolaAnna GualandrisMarco Presta OriginalPaper Pages: 102 - 116
A molecular and genetic analysis of renalglomerular capillary development Siobhan LoughnaPatricia HardmanAdrian S Woolf OriginalPaper Pages: 84 - 101
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications Masakazu ToiMassimo GionGiampietro Gasparini OriginalPaper Pages: 71 - 83
Novel forms of acidic fibroblast growth factor-1 are constitutively exported by β tumor cell lines independent from conventional secretion and apoptosis Gerhard ChristoforiSusanne Luef OriginalPaper Pages: 55 - 70
On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans Ram SasisekharanSteffen ErnstGanesh Venkataraman OriginalPaper Pages: 45 - 54
Clinical trials of anti-vascular agent group B Streptococcus toxin (CM101) Adrian L. Harris OriginalPaper Pages: 36 - 37
New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12 Laura MasieroWilliam D. FiggElise C. Kohn OriginalPaper Pages: 23 - 35
